A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
20 May 2020	Submitted	Original manuscript
20 May 2020	Author responded	Author comments - Jonathan Rilinger
20 May 2020	Reviewed	Reviewer Report - Kirsty Loudon
20 May 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
20 May 2020	Submitted	Manuscript version 2
Publishing
23 May 2020	Editorially accepted
3 Jun 2020	Article published	10.1186/s13063-020-04447-3

Back to article page